These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9761676)

  • 1. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge.
    Langedijk AC; Honegger A; Maat J; Planta RJ; van Schaik RC; Plückthun A
    J Mol Biol; 1998; 283(1):95-110. PubMed ID: 9761676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding.
    Proba K; Honegger A; Plückthun A
    J Mol Biol; 1997 Jan; 265(2):161-72. PubMed ID: 9020980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH; Sandmaier BM; Stayton PS
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody scFv fragments without disulfide bonds made by molecular evolution.
    Proba K; Wörn A; Honegger A; Plückthun A
    J Mol Biol; 1998 Jan; 275(2):245-53. PubMed ID: 9466907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
    Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L
    J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains.
    Saerens D; Conrath K; Govaert J; Muyldermans S
    J Mol Biol; 2008 Mar; 377(2):478-88. PubMed ID: 18262543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
    Pruett PS; Air GM
    Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y; Stollar BD
    J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule.
    Ouellette D; Alessandri L; Chin A; Grinnell C; Tarcsa E; Radziejewski C; Correia I
    Anal Biochem; 2010 Feb; 397(1):37-47. PubMed ID: 19766583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
    Röthlisberger D; Honegger A; Plückthun A
    J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant design and expression of human three-domain antibody against BoNTa].
    Wang H; Yin J; Shi J; Meng LL; Li PZ
    Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):223-5. PubMed ID: 15989265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
    J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
    Jäger M; Gehrig P; Plückthun A
    J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folding and oxidation of the antibody domain C(H)3.
    Thies MJ; Talamo F; Mayer M; Bell S; Ruoppolo M; Marino G; Buchner J
    J Mol Biol; 2002 Jun; 319(5):1267-77. PubMed ID: 12079363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of mouse monoclonal antibody 13-1 against a porphyrin derivative: identification of a disulfide bond in CDR-H3 of Mab 13-1.
    Akashi S; Kato K; Torizawa T; Dohmae N; Yamaguchi H; Kamachi M; Harada A; Imanaka T; Shimada I; Takio K
    Biochem Biophys Res Commun; 1997 Nov; 240(3):566-72. PubMed ID: 9398605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the stability of an antibody variable fragment by a combination of knowledge-based approaches: validation and mechanisms.
    Monsellier E; Bedouelle H
    J Mol Biol; 2006 Sep; 362(3):580-93. PubMed ID: 16926023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains.
    Honegger A; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):687-99. PubMed ID: 11397089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.